Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 39,034 shares at $16.66 ($650K) on 2023-11-07, disclosed to the SEC on 2023-11-08.
Scheduled sale ($650k) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.66 | 19,517 | $325K | 50.0% |
| 2 | $16.66 | 19,517 | $325K | 50.0% |
| Total | $16.66 avg | 39,034 | $650K | 100% |
| Filing → |
| IMGN | SELL | 2023-12-19 | $3.5M | — | Filing → |
| IMGN | SELL | 2023-12-01 | $9.7M | — | Filing → |
| IMGN | SELL | 2023-11-17 | $5.3M | — | Filing → |